Several other brokerages have also recently commented on EVH. Cowen raised their target price on shares of Evolent Health to $52.00 in a report on Monday, July 25th. Cowen increased their price target on shares of Evolent Health from $48.00 to $50.00 and gave the stock an outperform rating in a research report on Tuesday, June 21st. Canaccord Genuity Group increased their price target on shares of Evolent Health from $40.00 to $45.00 in a research report on Monday, May 9th. StockNews.com initiated coverage on shares of Evolent Health in a research report on Thursday, March 31st. They issued a hold rating for the company. Finally, Piper Sandler reduced their price target on shares of Evolent Health from $37.00 to $35.00 and set a na rating for the company in a research report on Tuesday, May 17th. One investment analyst has rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of Moderate Buy and an average price target of $43.56.
Evolent Health Stock Performance
Shares of EVH opened at $34.79 on Friday. Evolent Health has a one year low of $21.36 and a one year high of $35.45. The company has a 50-day moving average of $30.70 and a two-hundred day moving average of $28.62. The stock has a market cap of $3.19 billion, a price-to-earnings ratio of -91.55 and a beta of 1.86. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.21 and a quick ratio of 1.21.
Hedge Funds Weigh In On Evolent Health
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Vigilant Capital Management LLC acquired a new position in Evolent Health during the first quarter valued at approximately $32,000. Point72 Hong Kong Ltd acquired a new position in Evolent Health during the fourth quarter valued at approximately $72,000. Nisa Investment Advisors LLC grew its holdings in Evolent Health by 67.9% during the first quarter. Nisa Investment Advisors LLC now owns 2,250 shares of the technology company’s stock valued at $73,000 after purchasing an additional 910 shares during the last quarter. Advisor Group Holdings Inc. grew its holdings in Evolent Health by 38.9% during the fourth quarter. Advisor Group Holdings Inc. now owns 4,055 shares of the technology company’s stock valued at $113,000 after purchasing an additional 1,135 shares during the last quarter. Finally, AdvisorShares Investments LLC acquired a new position in Evolent Health during the first quarter valued at approximately $192,000. Institutional investors own 93.27% of the company’s stock.
About Evolent Health
Evolent Health, Inc, a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management.
- Get a free copy of the StockNews.com research report on Evolent Health (EVH)
- MarketBeat Podcast: Find Investing Opportunities For The Rest of 2022
- The Colgate-Palmolive Growth Outlook Brightens
- Deep Value High Yield Newell Brands Is Ready To Bottom
- These Stocks Outperformed Last Time There Was A Recession
- Does Rivian’s Stock Still Have A Future?
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for Evolent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health and related companies with MarketBeat.com's FREE daily email newsletter.